MedPath

Gut microbiome in children with gastrointestinal disease

Not Applicable
Active, not recruiting
Conditions
Diseases of the digestive system
Registration Number
KCT0008372
Lead Sponsor
Koera University Guro Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Active, not recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

1) IBD patients aged 13-25 years who were diagnosed with inflammatory bowel disease with onset under the age of 17, or undergoing treatment.
2) IBS patients aged 13-25 years who were diagnosed with irritable bowel syndrome with onset under the age of 17.

Exclusion Criteria

Individuals who do not consent to participate in the study.

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Alpha and beta diversity as well as composition of gut microbiota: 1) The characteristics of gut microbiota in pediatric patients with IBD will be analyzed in comparison to healthy individuals and those with IBS. 2) Differences in gut microbiota at the time of diagnosis or exacerbation of IBD will be analyzed for clinical relevance
Secondary Outcome Measures
NameTimeMethod
IBD group: clinical severity score (PCDAI, PUCAI);IBD group: endoscopic severity score (SES-CD, UCEIS);IBD/IBS group: fecal calprotectin;IBD group: use of biologics
© Copyright 2025. All Rights Reserved by MedPath